297
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Guanfacine extended-release for cannabis use disorder: a pilot feasibility trial

, , , , , & show all
Pages 44-48 | Received 06 Aug 2017, Accepted 13 May 2019, Published online: 24 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nour Azhari, Helen Hu, Kate Y. O’Malley, Megan E. Blocker, Frances R. Levin & Elias Dakwar. (2021) Ketamine-facilitated behavioral treatment for cannabis use disorder: A proof of concept study. The American Journal of Drug and Alcohol Abuse 47:1, pages 92-97.
Read now

Articles from other publishers (3)

Sercan Karabulut. (2024) Guanfacine Treatment in a Patient with Intravenous Buprenorphine/Naloxone Misuse. Case Reports in Psychiatry 2024, pages 1-3.
Crossref
Jason P. Connor, Daniel Stjepanović, Alan J. Budney, Bernard Le Foll & Wayne D. Hall. (2022) Clinical management of cannabis withdrawal. Addiction 117:7, pages 2075-2095.
Crossref
Amy F.T. Arnsten. (2020) Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species. Neurobiology of Learning and Memory 176, pages 107327.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.